Innovinc Group is organizing 9th Edition - Webinar on “Cancer Research & Therapy” on Oct 07-08, 2021 (Greenwich Mean Time) and it offers a remarkable opportunity to meet and make new contacts with global experts who are up to date with the latest developments in the Cancer Field. For the last 8 editions, the Cancer Conference has met this educational need—bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists—to improve the care received by patients with cancer.

After carefully observing the recent developments around the world and the threat of the Covid -19 pandemic, we have decided to conduct the event as a Virtual event by taking the attendees safety into consideration.

We welcome you to join our webinar to share and gain knowledge on latest research in Cancer!!!

Please participate freely and contribute to the open discussions during this Webinar.


Scientific Sessions

Webinar sessions may be geared toward participants with different levels of experience or different positions. Main scientific sessions include the following 22 tracks. Choose to follow one track or move between tracks to create your own personalized conference experience.


day 1 agenda

Thu , Oct 07, 2021

  • Title: Chopstick technique used in laparoendoscopic single site radical hysterectomy for early stage cervical cancer
    Li Deng, Army Medical University, China

  • Title: Strategies for the selection of oncoplastic techniques in the treatment of early-stage breast cancer patients
    Yuanqi Zhang, Affiliated Hospital of Guangdong Medical University, China

  • Title: Nuclear Transglutaminase 2 promote DNA damage repair in lung cancer cells through interacting with topoisomerase II⍺ to
    Yanyong Yang, The Second Military Medical Univeristy,  China

  • Title: Immune checkpoint inhibition for triple-negative breast cancer: Is VTCN1 a novel therapeutic target? 
    Shujun Fu, Hunan Normal University, China

  • Title: Study of effects of anthracycline drugs on myocardial function in breast cancer patients by quantitative analysis of layer-specific strain via 2D-STI technology
    Jing Wu, Nantong Third People’s Hospital, Nantong University, China

  • Title: DNA Methylation and Clinico-pathological Correlation in breast tumors
    Vivek Gupta, Government Institute of Medical Sciences, India

  • Title: Cell surface epitopes of tumor suppressor WWOX control cell-to-cell recognition, migration and homing
    Nan-ShanChang, National Cheng Kung University, Taiwan

  • Title: PNN and KCNQ1OT1:  potential biomarkers predictive of clinical outcome in colorectal cancer patients treated with adjuvant chemotherapy
    Stefania Nobili ,G. d'Annunzio University of Chieti-Pescara, Italy

  • Title: A spontaneously immortalized human breast cancer cell line as a tool for the identification of new molecular targets
    Antonella Mannini, Dept Experimental and Clinical Medicine/University of Florence,Italy

  • Title: DNA aptamers against vaccinia-related kinase (VRK) 1 in breast cancer cells
    Rebeca Carrión Marchante ,Hospital Universitario Ramón y Cajal,Spain

  • Title: Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer
    Johann Lechner , Practice Clinic Integrative Dental Medicine,Germany

  • Title: Breast lymphedema after conservative breast surgery: an up-to-date systematic review
    Mohamed Elkoret, West Hertfordshire Hospitals NHS Trust,UK

  • Title: EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer
    Xia Liu,University of Kentucky, USA

  • Title: Update on Breast Cancer Therapeutics and Biomarkers
    Carolina Restini, Michigan State University ,USA

  • Title: Fabrication of Dual Loaded Nanoparticles for HER2-Positive Breast Cancer Treatment Using Dispersion Polymerization
    Emmanuel O. Akala, Howard University, USA

  • Title: ZBP1, not RIPK1, mediates tumor necroptosis in breast cancer
    Zhenggang Liu, National Cancer Institute, NIH ,USA

  • Title: Clinical Experience with Machine Learning-Based Automated Treatment Planning for Whole Breast Radiation Therapy 
    Sua Yoo, Duke University, USA

  • Title: IL-15/IL-15Rα heterodimeric complex as cancer immunotherapy in murine breast cancer models
    Siqi Guo, Old Dominion University,USA 

  • Title: Surgical oophorectomy plus tamoxifen: the first option adjuvant therapy in premenopausal hormone receptor positive breast cancer 
    Richard Reed Love, Marquette University, USA

day 2 agenda

Fri , Oct 08, 2021

  • Title: Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function
    Yasuhiro Nagate, Osaka University,Japan

  • Title: Novel sustained-release oral nanosuspensions based on drug-polymeric coating and in-situ gel sedimentation as targeted colon-cancer drug delivery system
    Abdullah Samaa, King Abdulaziz University, Saudi Arabia

  • Title: Availability and Utilization of Fertility Preservation for Breast Cancer in Developing countries
    Nalini Kaul - Mahajan , Director Mother and Child Hospital & Ferticity Fertility Clinics, India

  • Title: Integration of fertility preservation in oncological services in limited resources setting
    Madhuri Patil, Clinical Director, Dr. Patil's Fertility and Endoscopy Clinic, India 

  • Title: The main BCR-ABL mRNA transcripts types and hematological features of newly chronic myeloid leukemia diagnosed in Burkina Faso
    Kima Donatien, Joseph KI-ZERBO University of Ouagadougou, Burkina faso

  • Title: Identification of a novel subpopulation of Caspase-4 positive Non-Small Cell Lung Cancer patients
    Rosalinda Sorrentino, University of Salerno, Italy

  • Title: Tumoral and stromal expression of MMP-2, MMP-9,MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival
    Jordana Maria Azevedo Martins, University of Campinas, Sao Paulo, Brazil

  • Title: Osteogenesis and Chondrogenesis Associated Genes Seem to be Involved in Development of Drug Resistance in Cancer Cells
    Jolanta Szenajch, Military Institute of Medicine, Poland

  • Title: Delivery Parameters in Photobiomodulation Therapy in Cancer Care
    Mark Cronshaw ,University of Birmingham, UK

  • Title: Prostate cancer (PCa) patients often progress to metastatic castration resistant prostate cancers (mCRPC) and treatment options are limited once they inevitably resist androgen receptor (AR) therapies
    Justin Hwang, University of Minnesota, USA

  • Title: Elucidating death kinetic of gastric cancer cells lines
    Leda Marcela Guzman Maluenda ,Pontifical Catholic University ,USA


Don t Miss This Amazing Conference And Opportunities